Pierrot Harvie
Precision Nanosystems (Canada)(CA)
Publications by Year
Research Areas
RNA Interference and Gene Delivery, Advanced biosensing and bioanalysis techniques, Virus-based gene therapy research, Nanoparticle-Based Drug Delivery, HIV Research and Treatment
Most-Cited Works
- → In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy(2008)350 cited
- → Biological barriers to cellular delivery of lipid-based DNA carriers(1999)169 cited
- → Use of Poly(ethylene glycol)–Lipid Conjugates to Regulate the Surface Attributes and Transfection Activity of Lipid–DNA Particles(2000)158 cited
- → Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency(2018)138 cited
- → Improved specificity of gene silencing by siRNAs containing unlocked nucleobase analogs(2010)108 cited
- → Characterization of Lipid DNA Interactions. I. Destabilization of Bound Lipids and DNA Dissociation(1998)86 cited
- → Increased Preclinical Efficacy of Irinotecan and Floxuridine Coencapsulated Inside Liposomes Is Associated With Tumor Delivery of Synergistic Drug Ratios(2006)83 cited
- → RNAi-based Therapeutics Targeting Survivin and PLK1 for Treatment of Bladder Cancer(2011)56 cited
- → An Amino Acid-based Amphoteric Liposomal Delivery System for Systemic Administration of siRNA(2011)49 cited
- → Targeting of Lipid-Protamine-DNA (LPD) Lipopolyplexes Using RGD Motifs(2003)48 cited